Patrick Delavault

1.7k citations
11 papers · 1.4k · 1 hit paper · h-index 8

Impact in

  • Genetics top 1%
    • Glioma Diagnosis and Treatment
    • Estrogen and related hormone effects
    • Nanoparticle-Based Drug Delivery

Papers in

    • Chronic Lymphocytic Leukemia Research 2
    • Glioma Diagnosis and Treatment 2
    • Estrogen and related hormone effects 1
    • Urinary Tract Infections Management 3
    • Pneumonia and Respiratory Infections 1

Patrick Delavault

10 papers receiving 1.4k citations

Patrick Delavault's Hit Papers

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma 2003 · 1.1k citations
1.1k0+7+15Years since publication2505007501k

Peers

Patrick Delavault
Comparison fields: 5 of 76
  • Genetics 834
  • Biomaterials 217
  • Pharmaceutical Science 119
  • Drug Discovery 3
  • Molecular Medicine 61
Replace S. Clifford Schold with:
S. Clifford Schold United States
Kévin Vanvarenberg Belgium
Montserrat A. Lara-Velazquez United States
Rawan Al‐kharboosh United States
田道锋 China
Noah Leviton Gorelick United States
James E. Dixon United Kingdom
Fangjing Wang United States
Kaikai Yi China
Matthias Van Woensel Belgium
Patrick Delavault relative to S. Clifford Schold United States S. Clifford Schold's profile →
Citations per field
00.5×5×11×
S. Clifford Schold · 1×
Citations per year

Countries citing papers authored by Patrick Delavault

Since Specialization
Citations

This map shows the geographic impact of Patrick Delavault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Delavault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Delavault more than expected).

Fields of papers citing papers by Patrick Delavault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Delavault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Delavault. The network helps show where Patrick Delavault may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick Delavault, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick Delavault Line = papers co-authored together Patrick Delavault links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma
Hit paper breakdown →
20031108
2 200794
3 200378
4 200662
5 200426
6 201221
7 200718
8
[Antibioprevention of recurrent cystitis. A randomized double-blind comparative trial of 2 dosages of pefloxacin].
199510
9
[Acute cystitis in women over 50 years of age. Efficacy of pefloxacin with single dose and norfloxacin for 10 days].
19936
10 19971
11
[Must pefloxacin and norfloxacin be studied separately against bacteria isolated from urinary tract infections by the API-ATB method?].
19950

About Patrick Delavault

Patrick Delavault is a scholar working on Genetics, Epidemiology, Applied Microbiology and Biotechnology, Clinical Biochemistry and Pharmacology, having authored 11 papers that have together received 1.4k indexed citations. Recurring topics across this work include Urinary Tract Infections Management (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Glioma Diagnosis and Treatment (2 papers), Cancer therapeutics and mechanisms (1 paper), Estrogen and related hormone effects (1 paper), Bacterial Identification and Susceptibility Testing (1 paper), Pneumonia and Respiratory Infections (1 paper) and Antibiotic Use and Resistance (1 paper). The work is most often cited by research in Genetics (834 citations), Biomaterials (217 citations), Pharmaceutical Science (119 citations), Drug Discovery (3 citations) and Molecular Medicine (61 citations). Patrick Delavault has collaborated with scholars based in France, United Kingdom and Germany. Frequent co-authors include Peter C. Warnke, Juha E. Jääskeläinen, Robert Olivares, Dana C. Hilt, Enoch B. Bortey, Zvi Ram, Manfred Westphal, Ian Roger Whittle, Joëlle Blumberg and Jacques-Pierre Moreau. Their work appears in journals such as Neuro-Oncology, Cancer Chemotherapy and Pharmacology, The Oncologist, British Journal of Cancer and Clinical Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact